Cruise lines will not be obliged to follow COVID-19 safety guidelines issued by the Centers for Disease Control and Prevention as of Saturday despite the omicron surge.
Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs), the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was led, and then asked for an extra 20 years to fully comply.
Last summer we coined a new term for mega-cap startups, as “unicorns” had become paradoxically ordinary. It was “dragons,” used to describe private companies valued at $12 billion or more, net of capital raised.
Verizon and AT&T on Sunday rejected a request by the U.S. government to delay rolling out its next-generation 5G wireless technology but offered to expand so-called “exclusion zones” for six months.
Products in the United States containing genetically modified organisms (GMOs) will be labeled as “bioengineered” under new food disclosure rules that took effect on Jan. 1.